The Intelligence: Drug gateway

The latest Ebola emergency is different from previous ones: there is no vaccine, and the kind of community-level work that stops the spread has been thinned by aid cuts. Britain is likely to get a new prime minister soon; we profile Andy Burnham, the Labour party’s polling favour ...  Show more

Atef Najib, a former security chief, is the highest-profile member of the Assad regime to go on trial. We ask why the speed, uneven spread and murky legal basis of justice troubles many Syrians. Our series leading up to America’s 250th birthday continues to plumb our archive. Tod ...  Show more

Our correspondent is travelling with Secretary of State Antony Blinken, who is on yet another gruelling tour of the Middle East trying to broker peace. What are the chances of a lasting deal? We examine the problems arising from Latin America’s falling fertility rate (11:06). And ...  Show more

For decades, Argentina’s labour unions have seemed like they can’t be touched. But the country’s new radical, libertarian president is daring to try. Ahead of Holocaust Memorial Day, two new films explore the tragedy (09:19). And, how Beyoncé made chrome cool again (16:44). Sign ...  Show more

On our website and in our app, “The Economist explains” is one of the best-read features. Today we invite a few of their authors to keep explaining. What is tranq dope? Why did France get so het up about bedbugs (06:48)? Can superstars’ stadium shows actually affect inflation (11 ...  Show more

Melting ski slopes, floods and droughts are enraging the continent’s citizens, but not quite enough for them to consider voting differently. Our correspondent explains what the electorate is weighing up. The world’s largest maker of glasses is branching out into tech (10:41). And ...  Show more